{"resourceType":"Bundle","id":"tests-7724a8d7-1e94-4acf-a435-7910e2c36555-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/7724a8d7-1e94-4acf-a435-7910e2c36555","resource":{"resourceType":"Patient","id":"7724a8d7-1e94-4acf-a435-7910e2c36555","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"62fd29d432e2f917c3627d83"}],"name":[{"family":"DENOMPass","given":["PSALessThan10BeforeTreatment"]}],"gender":"male","birthDate":"1979-12-31"},"request":{"method":"PUT","url":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"c7f58fda-6a5c-4726-9eea-d3e933a46365","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-category","code":"problem-list-item","display":"Problem List Item"},{"system":"http://snomed.info/sct","code":"439401001","display":"Diagnosis"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"onsetPeriod":{"start":"2020-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/c7f58fda-6a5c-4726-9eea-d3e933a46365"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"97de0dd2-2fdd-40f3-b49b-c9fc8f5a8754","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2025-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"performedDateTime":"2025-04-28T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/97de0dd2-2fdd-40f3-b49b-c9fc8f5a8754"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8db","resource":{"resourceType":"Observation","id":"4f514722-4587-4e72-bdd8-03d7ef32f680","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"2857-1","display":"Prostate specific Ag [Mass/volume] in Serum or Plasma","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"effectiveDateTime":"2025-04-24T08:00:00.000+00:00","valueQuantity":{"value":9.9,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/4f514722-4587-4e72-bdd8-03d7ef32f680"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"ae668b97-2a71-4827-9985-3f929db10eb9","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"effectiveDateTime":"2025-01-02T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/ae668b97-2a71-4827-9985-3f929db10eb9"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"2f8c13d4-ae2f-4eaa-a935-77906a71f96e","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"effectiveDateTime":"2025-04-26T08:00:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433361000124104","display":"Neoplasm of prostate primary tumor staging category T2a: Involves one-half of one lobe or less (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/2f8c13d4-ae2f-4eaa-a935-77906a71f96e"}},{"fullUrl":"https://madie.cms.gov/Observation/bone-scan-5337","resource":{"resourceType":"Observation","id":"46d9d553-1de9-4752-bcb5-295e0d55a5e6","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"25031-6","display":"NM Bone Views","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"effectiveDateTime":"2025-08-17T08:00:00.000+00:00","issued":"2025-08-17T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Observation/46d9d553-1de9-4752-bcb5-295e0d55a5e6"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-7d84","resource":{"resourceType":"Observation","id":"a42997f1-9e22-4552-8493-4828e353de52","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"effectiveDateTime":"2023-12-31T08:00:00.000+00:00","valueQuantity":{"value":15.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/a42997f1-9e22-4552-8493-4828e353de52"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-7d85","resource":{"resourceType":"Observation","id":"7224a5ba-4f04-446e-b8ea-602009e43f63","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"effectiveDateTime":"2025-08-17T08:00:00.000+00:00","valueQuantity":{"value":12.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/7224a5ba-4f04-446e-b8ea-602009e43f63"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"bf3387ca-ba7b-4dfc-b530-a5d516ae397e","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/7724a8d7-1e94-4acf-a435-7910e2c36555"},"payor":[{"reference":"Organization/4d7da20f-8773-4347-8f6b-80adcdcee1f4"}]},"request":{"method":"PUT","url":"Coverage/bf3387ca-ba7b-4dfc-b530-a5d516ae397e"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"4d7da20f-8773-4347-8f6b-80adcdcee1f4","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/4d7da20f-8773-4347-8f6b-80adcdcee1f4"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"2a921e66-8695-426b-b7b2-3d048d546abe","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/2a921e66-8695-426b-b7b2-3d048d546abe"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/b31b2269-fa22-425d-a66d-57b0ff56ee6b","resource":{"resourceType":"MeasureReport","id":"b31b2269-fa22-425d-a66d-57b0ff56ee6b","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"793815e2-56a3-4791-b6c9-cdbdddd5c432-parameters","parameter":[{"name":"subject","valueString":"7724a8d7-1e94-4acf-a435-7910e2c36555"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#793815e2-56a3-4791-b6c9-cdbdddd5c432-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Active Prostate Ca Diagnosis and meets all other denominator criteria (first treatment, tumor staging, PSA test, Gleason). Testing multiple PSA results with most recent  before treatment less than 10.\n"}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/b31b2269-fa22-425d-a66d-57b0ff56ee6b"}}]}